Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × irofulven × Clear all

NCT00124566 2016-01-18

Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms